https://www.marketscreener.com/quote/stock/MYMD-PHARMACEUTICALS-INC-47080603/news/MyMD-Announces-Preclinical-Study-Results-Showing-Novel-Cannabidiol-Analog-Supera-CBD-Reduced-Ac-45103832/?utm_source=telegram&utm_medium=social&utm_campaign=share